Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2016)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 0.76% |
| Sep 30, 2016 | 0.42% |
| Jun 30, 2016 | 0.23% |
| Mar 31, 2016 | 0.22% |
| Dec 31, 2015 | 0.11% |
| Sep 30, 2015 | 0.01% |
| Jun 30, 2015 | 0.01% |
| Mar 31, 2015 | 0.01% |
| Dec 31, 2014 | 0.01% |
| Mar 31, 2011 | 18.38% |
| Dec 31, 2010 | 71.82% |
| Sep 30, 2010 | -72.33% |